Positive Autoantibody Chronic Urticaria. Idiopathic urticaria
Conditions
Interventions
Intervention 1: Intervention group: "The first intervention group of Fexofenadine tablets 120 mg once daily for 3 months from Saha Pharmaceuticals, Doxepin tablets 10 mg once daily for 3 months from
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 70 Years
Inclusion criteria
Inclusion criteria: Patients with chronic urticaria in the age range of 20 to 70 years
Exclusion criteria
Exclusion criteria: pregnant and lactating females Patients with Physical Urticaria and Vasculitis Urticaria Patients with Colchicine-induced drug side effects
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| "Percentage of people with chronic urticaria who have autoimmune thyroiditis". Timepoint: "Measurement of thyroid autoantibodies at the beginning of the study (before the intervention) and 3 months after taking colchicine". Method of measurement: "Peripheral blood sample". | — |
Secondary
| Measure | Time frame |
|---|---|
| "The urticaria score in the Chronic Urticaria Quality of Life questionnaire". Timepoint: Comparison of the average total score of the Chronic Urticaria Quality of Life questionnaire in the study groups at the beginning of the study and 3 months after taking colchicine". Method of measurement: "Chronic Urticaria Quality of Life questionnaire".;" The urticaria score in the Urticaria Activity Score 7 questionnaire". Timepoint: " Comparison of the average total score of the Urticaria Activity Score 7 questionnaire in the study groups at the beginning of the study and 3 months after taking colchicine". Method of measurement: " Urticaria Activity Score 7 questionnaire". | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMasroor Babaeian
Shiraz University of Medical Sciences
Outcome results
None listed